Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 2/20 | 0.50 |
| ▸ | GCGR | P47871 | 1/20 | 0.50 |
| ▸ | GIPR | P48546 | 1/20 | 0.50 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.45 |
| ▸ | VIPR2 | P41587 | 4/20 | 0.44 |
| ▸ | ECE1 | P42892 | 1/20 | 0.44 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.44 |
| ▸ | TFPI | P10646 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8724081 | 0.90 | NPY4R (0.49) | — | |
| SCHEMBL10335931 | 0.89 | VIPR1 (0.46) | VIPR1BACE1RXFP1VIPR2 | |
| SCHEMBL31232429 | 0.89 | GLP1R (0.49) | GLP1RGCGRGIPRVIPR1BACE1 | |
| SCHEMBL30420443 | 0.89 | GLP1R (0.50) | GLP1RGCGRGIPRVIPR1BACE1 | |
| SCHEMBL30262036 | 0.89 | VIPR1 (0.52) | VIPR1BACE1VIPR2TFPI | |
| SCHEMBL29625167 | 0.88 | NPY4R (0.49) | BACE1TFPI | |
| SCHEMBL31031560 | 0.88 | TFPI (0.49) | GLP1RGCGRGIPRVIPR1ECE1 | |
| SCHEMBL30159395 | 0.88 | BACE1 (0.51) | GLP1RGCGRGIPRVIPR1BACE1 | |
| SCHEMBL31462927 | 0.87 | TFPI (0.48) | GLP1RGCGRGIPRVIPR1RXFP1 | |
| SCHEMBL29901564 | 0.87 | BACE1 (0.49) | GLP1RGCGRGIPRVIPR1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-116785403-A | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |